newsfilter
← Latest News
PR Newswire·

Immunic, Inc. Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Immunic, Inc. (Nasdaq: IMUX), a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic and...